References
Anderson, M. G., Frenkel, L. D., Homann, S., & Guffey, J. (2003). A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values. Pediatr Infect Dis J, 22 (12), 1093-1096; discussion 1096-1098. doi:10.1097/01.inf.0000101821.61387.a5
Angelo, K. M., Petersen, B. W., Hamer, D. H., Schwartz, E., & Brunette, G. (2019). Monkeypox transmission among international travellers—serious monkey business? In (Vol. 26, pp. taz002): Oxford University Press.
Babkin, I. V., Babkina, I. N., & Tikunova, N. V. (2022). An Update of Orthopoxvirus Molecular Evolution. Viruses, 14 (2), 388. doi:10.3390/v14020388
Baker, R. O., Bray, M., & Huggins, J. W. (2003). Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections.Antiviral Res, 57 (1-2), 13-23. doi:10.1016/s0166-3542(02)00196-1
Bayer-Garner, I. B. (2005). Monkeypox virus: histologic, immunohistochemical and electron-microscopic findings. J Cutan Pathol, 32 (1), 28-34. doi:10.1111/j.0303-6987.2005.00254.x
Berhanu, A., Prigge, J. T., Silvera, P. M., Honeychurch, K. M., Hruby, D. E., & Grosenbach, D. W. (2015). Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection. Antimicrobial agents and chemotherapy, 59 (7), 4296-4300.
Bhunu, C. P., Mushayabasa, S., & Hyman, J. (2012). Modelling HIV/AIDS and monkeypox co-infection. Applied Mathematics and Computation, 218 (18), 9504-9518.
Breman, J. G. (2000). Monkeypox: an emerging infection for humans?Emerging infections 4 , 45-67.
Brown, K., & Leggat, P. A. (2016). Human Monkeypox: Current State of Knowledge and Implications for the Future. Trop Med Infect Dis, 1 (1), 8. doi:10.3390/tropicalmed1010008
Bunge, E. M., Hoet, B., Chen, L., Lienert, F., Weidenthaler, H., Baer, L. R., & Steffen, R. (2022). The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis, 16 (2), e0010141. doi:10.1371/journal.pntd.0010141
Costello, V., Sowash, M., Gaur, A., Cardis, M., Pasieka, H., Wortmann, G., & Ramdeen, S. (2022). Imported Monkeypox from International Traveler, Maryland, USA, 2021. Emerg Infect Dis, 28 (5), 1002-1005. doi:10.3201/eid2805.220292
Damon, I. K. (2011). Status of human monkeypox: clinical disease, epidemiology and research. Vaccine, 29 Suppl 4 , D54-59. doi:10.1016/j.vaccine.2011.04.014
Durski, K. N., McCollum, A. M., Nakazawa, Y., Petersen, B. W., Reynolds, M. G., Briand, S., . . . Khalakdina, A. (2018). Emergence of monkeypox—west and central Africa, 1970–2017. Morbidity and Mortality Weekly Report, 67 (10), 306.
Echekwube, P., Mbaave, P., Abidakun, O., Utoo, B., & Swende, T. (2020). Human Monkeypox and Human Immunodeficiency Virus Co-infection: A Case Series in Makurdi, Benue State, Nigeria. Journal of BioMedical Research and Clinical Practice, 3 (2), 375-381.
Edghill-Smith, Y., Golding, H., Manischewitz, J., King, L. R., Scott, D., Bray, M., . . . Franchini, G. (2005). Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med, 11 (7), 740-747. doi:10.1038/nm1261
Eltvedt, A. K., Christiansen, M., & Poulsen, A. (2020). A Case Report of Monkeypox in a 4-Year-Old Boy from the DR Congo: Challenges of Diagnosis and Management. Case Rep Pediatr, 2020 , 8572596. doi:10.1155/2020/8572596
Erez, N., Achdout, H., Milrot, E., Schwartz, Y., Wiener-Well, Y., Paran, N., . . . Schwartz, E. (2019). Diagnosis of Imported Monkeypox, Israel, 2018. Emerg Infect Dis, 25 (5), 980-983. doi:10.3201/eid2505.190076
Fleischauer, A. T., Kile, J. C., Davidson, M., Fischer, M., Karem, K. L., Teclaw, R., . . . Kuehnert, M. J. (2005). Evaluation of human-to-human transmission of monkeypox from infected patients to health care workers. Clin Infect Dis, 40 (5), 689-694. doi:10.1086/427805
Grant, R., Nguyen, L. L., & Breban, R. (2020). Modelling human-to-human transmission of monkeypox. Bull World Health Organ, 98 (9), 638-640. doi:10.2471/BLT.19.242347
Heraud, J. M., Edghill-Smith, Y., Ayala, V., Kalisz, I., Parrino, J., Kalyanaraman, V. S., . . . Franchini, G. (2006). Subunit recombinant vaccine protects against monkeypox. J Immunol, 177 (4), 2552-2564. doi:10.4049/jimmunol.177.4.2552
Hobson, G., Adamson, J., Adler, H., Firth, R., Gould, S., Houlihan, C., . . . Wingfield, T. (2021). Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021. Euro Surveill, 26 (32). doi:10.2807/1560-7917.ES.2021.26.32.2100745
Hoff, N. A., Morier, D. S., Kisalu, N. K., Johnston, S. C., Doshi, R. H., Hensley, L. E., . . . Rimoin, A. W. (2017). Varicella Co-infection in Patients with Active Monkeypox in the Democratic Republic of the Congo. Ecohealth, 14 (3), 564-574. doi:10.1007/s10393-017-1266-5
Hughes, C., McCollum, A., Pukuta, E., Karhemere, S., Nguete, B., Lushima, R. S., . . . Wemakoy, O. (2014). Ocular complications associated with acute monkeypox virus infection, DRC.International Journal of Infectious Diseases, 21 , 276-277.
Hughes, C. M., Liu, L., Davidson, W. B., Radford, K. W., Wilkins, K., Monroe, B., . . . Kabamba, J. (2021). A Tale of Two Viruses: Coinfections of Monkeypox and Varicella Zoster Virus in the Democratic Republic of Congo. The American Journal of Tropical Medicine and Hygiene, 104 (2), 604.
Huhn, G. D., Bauer, A. M., Yorita, K., Graham, M. B., Sejvar, J., Likos, A., . . . Kuehnert, M. J. (2005). Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis, 41 (12), 1742-1751. doi:10.1086/498115
Hutson, C. L., Kondas, A. V., Mauldin, M. R., Doty, J. B., Grossi, I. M., Morgan, C. N., . . . Kling, C. (2021). Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model. Msphere, 6 (1), e00927-00920.
Jabeen, C., & Umbreen, G. (2017). Monkeypox transmission, need and treatment of humans with an antiviral drug. International Journal of Social Sciences and Management, 4 (2), 77-79.
Kabuga, A. I., & El Zowalaty, M. E. (2019). A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria. J Med Virol, 91 (4), 533-540. doi:10.1002/jmv.25348
Karem, K. L., Reynolds, M., Braden, Z., Lou, G., Bernard, N., Patton, J., & Damon, I. K. (2005). Characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clinical and Vaccine Immunology, 12 (7), 867-872.
Keckler, M. S., Salzer, J. S., Patel, N., Townsend, M. B., Nakazawa, Y. J., Doty, J. B., . . . Karem, K. L. (2020). IMVAMUNE® and ACAM2000® Provide Different Protection against Disease When Administered Postexposure in an Intranasal Monkeypox Challenge Prairie Dog Model.Vaccines, 8 (3), 396.
Leong, W.-Y. (2020). COVID-19’s impact on travel medicine surpasses that of all other emerging viral diseases. In (Vol. 27, pp. taaa221): Oxford University Press.
Macneil, A., Reynolds, M. G., Braden, Z., Carroll, D. S., Bostik, V., Karem, K., . . . Damon, I. K. (2009). Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity. Clin Infect Dis, 48 (1), e6-8. doi:10.1086/595552
MacNeil, A., Reynolds, M. G., Carroll, D. S., Karem, K., Braden, Z., Lash, R., . . . Damon, I. K. (2009). Monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo.Am J Trop Med Hyg, 80 (4), 503-507.
Mahase, E. (2022a). Monkeypox: What do we know about the outbreaks in Europe and North America? In: British Medical Journal Publishing Group.
Mahase, E. (2022b). Seven monkeypox cases are confirmed in England. In: British Medical Journal Publishing Group.
Mauldin, M. R., McCollum, A. M., Nakazawa, Y. J., Mandra, A., Whitehouse, E. R., Davidson, W., . . . Reynolds, M. G. (2022). Exportation of Monkeypox Virus From the African Continent. J Infect Dis, 225 (8), 1367-1376. doi:10.1093/infdis/jiaa559
Ng, O. T., Lee, V., Marimuthu, K., Vasoo, S., Chan, G., Lin, R. T. P., & Leo, Y. S. (2019). A case of imported Monkeypox in Singapore.Lancet Infect Dis, 19 (11), 1166. doi:10.1016/S1473-3099(19)30537-7
Nguyen, P. Y., Ajisegiri, W. S., Costantino, V., Chughtai, A. A., & MacIntyre, C. R. (2021). Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020.Emerg Infect Dis, 27 (4), 1007. doi:10.3201/eid2704.203569
Nolen, L. D., Osadebe, L., Katomba, J., Likofata, J., Mukadi, D., Monroe, B., & Doty, J. (2015). Introduction of monkeypox into a community and household: risk factors and zoonotic reservoirs in the Democratic Republic of the Congo. The American Journal of Tropical Medicine and Hygiene, 93 (2), 410.
Ogoina, D., Iroezindu, M., James, H. I., Oladokun, R., Yinka-Ogunleye, A., Wakama, P., . . . Ihekweazu, C. (2020). Clinical Course and Outcome of Human Monkeypox in Nigeria. Clin Infect Dis, 71 (8), e210-e214. doi:10.1093/cid/ciaa143
Ogoina, D., Mohammed, A., Yinka-Ogunleye, A., & Ihekweazu, C. (2022). A case of suicide during the 2017 monkeypox outbreak in Nigeria.IJID Regions .
Parker, S., Nuara, A., Buller, R. M., & Schultz, D. A. (2007). Human monkeypox: an emerging zoonotic disease. Future Microbiol, 2 (1), 17-34. doi:10.2217/17460913.2.1.17
Petersen, B. W. (2021). Clinical guidance for the use of JYNNEOS.
Petersen, B. W., Karem, K. L., & Damon, I. K. (2014). Orthopoxviruses: Variola, Vaccinia, Cowpox, and Monkeypox. In Viral Infections of Humans (pp. 501-517): Springer.
Petersen, E., Kantele, A., Koopmans, M., Asogun, D., Yinka-Ogunleye, A., Ihekweazu, C., & Zumla, A. (2019). Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. Infect Dis Clin North Am, 33 (4), 1027-1043. doi:10.1016/j.idc.2019.03.001
Quiner, C. A., Moses, C., Monroe, B. P., Nakazawa, Y., Doty, J. B., Hughes, C. M., . . . Reynolds, M. G. (2017). Presumptive risk factors for monkeypox in rural communities in the Democratic Republic of the Congo. PloS one, 12 (2), e0168664. doi:10.1371/journal.pone.0168664
Rao, A. K., Schulte, J., Chen, T.-H., Hughes, C. M., Davidson, W., Neff, J. M., . . . Liddell, A. (2022). Monkeypox in a Traveler Returning from Nigeria—Dallas, Texas, July 2021. Morbidity and Mortality Weekly Report, 71 (14), 509.
Rao, A. K., Schulte, J., Chen, T. H., Hughes, C. M., Davidson, W., Neff, J. M., . . . July Monkeypox Response, T. (2022). Monkeypox in a Traveler Returning from Nigeria - Dallas, Texas, July 2021. MMWR Morb Mortal Wkly Rep, 71 (14), 509-516. doi:10.15585/mmwr.mm7114a1
Reed, K. D., Melski, J. W., Graham, M. B., Regnery, R. L., Sotir, M. J., Wegner, M. V., . . . Damon, I. K. (2004). The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med, 350 (4), 342-350. doi:10.1056/NEJMoa032299
Reynolds, M. G., Carroll, D. S., & Karem, K. L. (2012). Factors affecting the likelihood of monkeypox’s emergence and spread in the post-smallpox era. Curr Opin Virol, 2 (3), 335-343. doi:10.1016/j.coviro.2012.02.004
Reynolds, M. G., & Damon, I. K. (2012). Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol, 20 (2), 80-87. doi:10.1016/j.tim.2011.12.001
Reynolds, M. G., Davidson, W. B., Curns, A. T., Conover, C. S., Huhn, G., Davis, J. P., . . . Damon, I. K. (2007). Spectrum of infection and risk factors for human monkeypox, United States, 2003. Emerg Infect Dis, 13 (9), 1332-1339. doi:10.3201/eid1309.070175
Reynolds, M. G., Yorita, K. L., Kuehnert, M. J., Davidson, W. B., Huhn, G. D., Holman, R. C., & Damon, I. K. (2006). Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis, 194 (6), 773-780. doi:10.1086/505880
Russo, A. T., Berhanu, A., Bigger, C. B., Prigge, J., Silvera, P. M., Grosenbach, D. W., & Hruby, D. (2020). Co-administration of tecovirimat and ACAM2000 in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge. Vaccine, 38 (3), 644-654. doi:10.1016/j.vaccine.2019.10.049
Seguin, D., & Stoner Halpern, J. (2004). Triage of a febrile patient with a rash: a comparison of chickenpox, monkeypox, and smallpox.Disaster Manag Response, 2 (3), 81-86. doi:10.1016/j.dmr.2004.06.013
Sejvar, J. J., Chowdary, Y., Schomogyi, M., Stevens, J., Patel, J., Karem, K., . . . Damon, I. K. (2004). Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis, 190 (10), 1833-1840. doi:10.1086/425039
Silenou, B. C., Tom-Aba, D., Adeoye, O., Arinze, C. C., Oyiri, F., Suleman, A. K., . . . Krause, G. (2020). Use of surveillance outbreak response management and analysis system for human monkeypox outbreak, Nigeria, 2017–2019. Emerging infectious diseases, 26 (2), 345.
Simpson, K., Heymann, D., Brown, C. S., Edmunds, W. J., Elsgaard, J., Fine, P., . . . Ihekweazu, C. (2020). Human monkeypox–After 40 years, an unintended consequence of smallpox eradication. Vaccine, 38 (33), 5077-5081.
Smith, S. K., Olson, V. A., Karem, K. L., Jordan, R., Hruby, D. E., & Damon, I. K. (2009). In vitro efficacy of ST246 against smallpox and monkeypox. Antimicrob Agents Chemother, 53 (3), 1007-1012. doi:10.1128/AAC.01044-08
Tabasi, S. (2018). Skin rashes that involve palms and soles: an internist’s view. Ann Nurs Primary Care. 2018; 1 (2), 1012 .
Uwishema, O., Adanur, I., Babatunde, A. O., Hasan, M. M., Elmahi, O. K. O., Olajumoke, K. B., . . . Essar, M. Y. (2021). Viral infections amidst COVID-19 in Africa: Implications and recommendations. J Med Virol, 93 (12), 6798-6802. doi:10.1002/jmv.27211
Vaughan, A., Aarons, E., Astbury, J., Balasegaram, S., Beadsworth, M., Beck, C. R., . . . Wilburn, J. (2018a). Two cases of monkeypox imported to the United Kingdom, September 2018. Euro Surveill, 23 (38), 1800509. doi:10.2807/1560-7917.ES.2018.23.38.1800509
Vaughan, A., Aarons, E., Astbury, J., Balasegaram, S., Beadsworth, M., Beck, C. R., . . . Wilburn, J. (2018b). Two cases of monkeypox imported to the United Kingdom, September 2018. Euro Surveill, 23 (38). doi:10.2807/1560-7917.Es.2018.23.38.1800509
Vaughan, A., Aarons, E., Astbury, J., Brooks, T., Chand, M., Flegg, P., . . . Dunning, J. (2020). Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018. Emerg Infect Dis, 26 (4), 782-785. doi:10.3201/eid2604.191164
Walensky, R. P. (2022). Centers for Disease Control and Prevention justification of appropriation estimates for Appropriations Committees fiscal year 2023.
Walker, M. (2022). Monkeypox Virus Hosts and Transmission Routes: A Systematic Review of a Zoonotic Pathogen.
Wardiana, M., Rahmadewi, D. M., & Sawitri, D. (2021). Chickenpox Mimicking Monkeypox in Adult with Diabetes Mellitus and Acute Kidney Injury: Diagnosis and Management. Berkala Ilmu Kesehatan Kulit dan Kelamin, 33 (3), 213-223.
Weinstein, R. A., Nalca, A., Rimoin, A. W., Bavari, S., & Whitehouse, C. A. (2005). Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clinical Infectious Diseases, 41 (12), 1765-1771.
Xiao, Y., & Isaacs, S. N. (2010). Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections. Viruses, 2 (10), 2381-2403. doi:10.3390/v2102381
Yinka-Ogunleye, A., Aruna, O., Dalhat, M., Ogoina, D., McCollum, A., Disu, Y., . . . Team, C. D. C. M. O. (2019). Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report.Lancet Infect Dis, 19 (8), 872-879. doi:10.1016/S1473-3099(19)30294-4